Literature DB >> 3892296

Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. Comparison with onchocerciasis.

K M Leiferman, S J Ackerman, H A Sampson, H S Haugen, P Y Venencie, G J Gleich.   

Abstract

Although blood eosinophilia is commonly present in atopic dermatitis, accumulation of tissue eosinophils is not prominent. To determine whether eosinophil degranulation occurs in lesions of atopic dermatitis, we analyzed tissues by immunofluorescence for the presence of the eosinophil-granule major basic protein. Twenty biopsy specimens from 18 patients with atopic dermatitis were studied, and all showed major basic protein staining outside eosinophils. In 18 specimens, the staining was fibrillar, was located in the upper half of the dermis, and was similar to the distribution of elastic fibers. Twelve specimens with fibrillar staining also showed major basic protein staining in the form of extracellular granules. One specimen from unaffected skin showed minimal faint, fine, fluorescing fibrils, but there was marked deposition of the protein in affected skin. The fibrillar pattern of major basic protein staining in atopic dermatitis was very similar to that seen in lichenified lesions of untreated onchocerciasis. These results suggest that eosinophils commonly release granule proteins in the dermis and that assessment of eosinophil involvement in disease cannot be based simply on numbers of eosinophils in tissue.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3892296     DOI: 10.1056/NEJM198508013130502

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  52 in total

1.  Eosinophil granule-derived major basic protein induces IL-8 expression in human intestinal myofibroblasts.

Authors:  G T Furuta; S J Ackerman; J Varga; A M Spiess; M Y Wang; B K Wershil
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

Review 2.  Immunopathology of atopic dermatitis.

Authors:  D Y Leung
Journal:  Springer Semin Immunopathol       Date:  1992

3.  Eosinophil cationic protein in atopic eczema.

Authors:  T Jakob; K Hermann; J Ring
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

4.  Toxicity of eosinophil MBP is repressed by intracellular crystallization and promoted by extracellular aggregation.

Authors:  Alice Soragni; Shida Yousefi; Christina Stoeckle; Angela B Soriaga; Michael R Sawaya; Evelyne Kozlowski; Inès Schmid; Susanne Radonjic-Hoesli; Sebastien Boutet; Garth J Williams; Marc Messerschmidt; M Marvin Seibert; Duilio Cascio; Nadia A Zatsepin; Manfred Burghammer; Christian Riekel; Jacques-Philippe Colletier; Roland Riek; David S Eisenberg; Hans-Uwe Simon
Journal:  Mol Cell       Date:  2015-02-26       Impact factor: 17.970

5.  Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis.

Authors:  J M Spergel; E Mizoguchi; H Oettgen; A K Bhan; R S Geha
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

Review 6.  [Anti-interleukin-5 therapy for eosinophilic diseases].

Authors:  D Simon; L R Braathen; H-U Simon
Journal:  Hautarzt       Date:  2007-02       Impact factor: 0.751

Review 7.  IgE-dependent histamine-releasing factors.

Authors:  H A Sampson; S M MacDonald
Journal:  Springer Semin Immunopathol       Date:  1993

8.  Eosinophil granule proteins expressed in ocular cicatricial pemphigoid.

Authors:  A Heiligenhaus; J Schaller; S Mauss; S Engelbrecht; J E Dutt; C S Foster; K P Steuhl
Journal:  Br J Ophthalmol       Date:  1998-03       Impact factor: 4.638

9.  Marked deposition of eosinophil-derived neurotoxin in adult patients with eosinophilic esophagitis.

Authors:  Gail M Kephart; Jeffrey A Alexander; Amindra S Arora; Yvonne Romero; Thomas C Smyrk; Nicholas J Talley; Hirohito Kita
Journal:  Am J Gastroenterol       Date:  2009-11-03       Impact factor: 10.864

10.  Extensive deposition of eosinophil peroxidase in Hodgkin's and non-Hodgkin's lymphomas.

Authors:  M K Samoszuk; B N Nathwani; R J Lukes
Journal:  Am J Pathol       Date:  1986-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.